Recent discussions on X about Cigna Group (CI) have centered around the broader health insurance sector's challenges, particularly with rising medical costs and revised guidance from major players. Many users have expressed concern over a sector-wide selloff, noting a dip in CI's stock price amid fears of shrinking demand and increasing specialty drug expenses. The tone reflects unease about how these pressures might impact profitability.
Additionally, there’s a mix of frustration and skepticism regarding Cigna's business practices, with some highlighting perceived discrepancies in drug pricing across Medicare plans. Others have compared the company's long-term performance favorably against competitors, pointing to a strong five-year return as a potential bright spot. These conversations underscore a complex landscape for CI as it navigates both operational and market headwinds.
Note: This discussion summary was generated from an AI condensation of post data.
Cigna Group Congressional Stock Trading
Members of Congress have traded $CI stock 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CI stock by members of Congress over the last 6 months:
- REPRESENTATIVE JARED MOSKOWITZ has traded it 2 times. They made 2 purchases worth up to $30,000 on 05/15 and 0 sales.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 02/24 and 1 sale worth up to $50,000 on 05/12.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/19 and 1 sale worth up to $15,000 on 03/03.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 02/25.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 01/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Cigna Group Insider Trading Activity
Cigna Group insiders have traded $CI stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CI stock by insiders over the last 6 months:
- DAVID CORDANI (Chairman & CEO) sold 26,527 shares for an estimated $8,173,499
- NOELLE K EDER (See Remarks) sold 9,944 shares for an estimated $3,182,080
- NICOLE S JONES (See Remarks) sold 4,904 shares for an estimated $1,511,020
- ELDER GRANGER sold 2,376 shares for an estimated $737,391
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Cigna Group Hedge Fund Activity
We have seen 741 institutional investors add shares of Cigna Group stock to their portfolio, and 758 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 1,768,555 shares (-99.7%) from their portfolio in Q2 2025, for an estimated $584,648,911
- JPMORGAN CHASE & CO added 1,215,575 shares (+23.9%) to their portfolio in Q1 2025, for an estimated $399,924,175
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,094,327 shares (+10.0%) to their portfolio in Q1 2025, for an estimated $360,033,583
- GQG PARTNERS LLC added 865,092 shares (+21.5%) to their portfolio in Q1 2025, for an estimated $284,615,268
- FMR LLC added 856,588 shares (+6.9%) to their portfolio in Q1 2025, for an estimated $281,817,452
- AMUNDI removed 753,083 shares (-33.4%) from their portfolio in Q1 2025, for an estimated $247,764,307
- VOLORIDGE INVESTMENT MANAGEMENT, LLC removed 626,675 shares (-97.4%) from their portfolio in Q1 2025, for an estimated $206,176,075
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Cigna Group Government Contracts
We have seen $3,617,216 of award payments to $CI over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- THE MINIMUM TASK ORDER AGAINST INDEFINITE DELIVERY INDEFINITE QUANTITY CONTRACT (IDIQ), W519TC-25-D-2008, F...: $3,262,504
- CONUS STUDENTS MEDICAL INS 2024: $299,154
- VEHICLE INSURANCE: $55,557
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Cigna Group Analyst Ratings
Wall Street analysts have issued reports on $CI in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 06/26/2025
- Barclays issued a "Overweight" rating on 06/02/2025
- Guggenheim issued a "Buy" rating on 05/23/2025
- Truist Securities issued a "Buy" rating on 05/12/2025
- Raymond James issued a "Strong Buy" rating on 05/05/2025
- Piper Sandler issued a "Overweight" rating on 05/05/2025
- Morgan Stanley issued a "Overweight" rating on 05/05/2025
To track analyst ratings and price targets for Cigna Group, check out Quiver Quantitative's $CI forecast page.
Cigna Group Price Targets
Multiple analysts have issued price targets for $CI recently. We have seen 14 analysts offer price targets for $CI in the last 6 months, with a median target of $382.0.
Here are some recent targets:
- Ben Hendrix from RBC Capital set a target price of $371.0 on 06/26/2025
- Andrew Mok from Barclays set a target price of $385.0 on 06/02/2025
- Jason Cassorla from Guggenheim set a target price of $388.0 on 05/23/2025
- David Macdonald from Truist Securities set a target price of $405.0 on 05/12/2025
- John Ransom from Raymond James set a target price of $385.0 on 05/05/2025
- Jessica Tassan from Piper Sandler set a target price of $374.0 on 05/05/2025
- Erin Wright from Morgan Stanley set a target price of $390.0 on 05/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
